Jobs / United States / Astrazeneca Pharmaceuticals Lp
Cell Therapy Strategy and Commercial Executive Director
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles1 certified filing for “Executive Director, VA Program Lead” (Architectural and Engineering Managers) in VA: $347k–$347k, median $347k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Last confirmed live 1 day agoWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Within the AstraZeneca Cell Therapy Enterprise, our ambition is to realize the full potential of cell therapy for people living with cancer, immune-mediated and rare diseases around the world. This unit has responsibility for the value chain from discovery through to late-stage development and commercialization. We are rapidly progressing a broad pipeline of cell therapies in collaboration with AstraZeneca’s Therapeutic Area Units. The Strategy and Commercial Executive Director , Cell Therapy Strategy and Commercial (CTSC), is a high-impact leadership role accountable for shaping and driving the end-to-end strategy for a defined indication or disease area within Cell Therapy. You will lead global commercial and strategic initiatives within the Cell Therapy Enterprise CTU)—including business development and competitive intelligence—partnering with Therapeutic Areas on clinical strategy, collaborating with in-market commercial and medical affairs on launch readiness, and aligning with global pricing and brand teams. Working cross-functionally with senior leaders, you will define early asset, disease, and portfolio strategies through PH3IDs. Reporting to the VP, Cell Therapy Strategy and Commercial, you will be a key architect of the company’s Cell Therapy strategy and lead cross-functional execution. Key Accountabilities: Deliver end-to-end Strategy, including: • Clear understanding and prioritization of current and future unmet needs • Indication-level strategic vision for both near-term and long-term • Integrated clinical strategy across all cell therapy platforms within the same indication • Work with global Clinical and ClinOps within respective TAs to develop comprehensive development strategy • Competitive early pipeline / long-term portfolio and life cycle management • Above-asset initiatives (e.g., Translational Medicine, Precision Medicine, Data Sciences) Own insights generation for R&D and commercial activities • Oversees and guides development and integration of industry-leading competitive intelligence, customer insight, market intelligence and analytics helping the organization to frame business problems and opportunities • Shape future-proofed strategies and deliver sustainably differentiated brands/early assets, business development opportunities and TA strategies • Responsible for the robustness and transparency of the forecasts for PH3IDs • Bring an intelligence-driven perspective to strategic recommendations by synthesizing insights from diverse sources and publicly available information at the brand and Therapeutic Area level for internal and external communication • Responsible for creating and curating evidence bank from real world data sources to support the PH3ID forecasts created within the team Lead global commercial cell therapy within indication • Build the referral capabilities between specific disease areas and the Cell Therapy delivery centers • Partners closely across different areas of Cell Therapy, Global Commercial, in-market commercial and medical affairs teams to ensure execution of global strategy • Lead and collaborate with cross-functional teams (e.g., GPTs, Clinical Development, Discovery, BD, Lifecycle and Pipeline, Competitive Intelligence) to develop disease area strategy content • Provide strategic counselling to Global Clinical Strategy Head (GCSH), Global Commercial and Medical Affairs leadership, and other senior leaders Basic Qualifications: • BA/BS and 10 years of experience in life sciences or consulting firm with focus in life science programs • OR MS/MBA and 8+ years of experience in life sciences or consulting firm with focus in life science programs • OR PhD or MD and 5+ of experience in life sciences or consulting firm with focus in lif